Tactile Medical's Q3 Net Income Soars 59% on Strong Sales Growth

TL;DR

**TCMD crushed Q3 with a 59% net income jump, but watch that cash burn from buybacks and debt payments.**

AI Summary

Tactile Systems Technology Inc. (TCMD) reported a robust financial performance for the three and nine months ended September 30, 2025. Total revenue for the three months increased by 17.3% to $85.755 million from $73.093 million in the prior year, driven primarily by a 21.7% surge in sales revenue to $76.890 million. Net income for the three-month period significantly rose by 59.2% to $8.209 million, up from $5.155 million in 2024. For the nine months, total revenue grew 8.0% to $225.928 million, and net income increased by 16.7% to $8.452 million. The company's cash position decreased to $65.965 million from $94.367 million at December 31, 2024, largely due to $26.250 million in note payable payments and $26.562 million in common stock repurchases. Operating expenses increased, with sales and marketing up 11.1% to $29.809 million for the quarter, and reimbursement, general and administrative expenses rising 18.3% to $21.442 million. The company continues to manage seasonality, with higher revenue typically in Q3 and Q4 due to patient insurance deductibles being met.

Why It Matters

TCMD's strong Q3 performance, particularly the significant net income growth, signals effective execution in a competitive medical device market. For investors, this indicates potential for continued profitability and a healthy demand for their lymphedema and respiratory products, especially as patients meet insurance deductibles. Employees benefit from a growing company, potentially leading to job security and expansion. Customers gain from continued access to essential medical devices like Flexitouch Plus and AffloVest. The competitive landscape, with new entrants and product innovations, means TCMD's ability to maintain sales momentum and manage operating costs is crucial for long-term market share.

Risk Assessment

Risk Level: medium — The company faces a medium risk level due to a significant decrease in cash from $94.367 million at December 31, 2024, to $65.965 million at September 30, 2025, primarily driven by $26.250 million in note payable payments and $26.562 million in common stock repurchases. While net income is up, this cash outflow could impact future liquidity if not managed carefully, especially given the seasonality of their business.

Analyst Insight

Investors should monitor TCMD's cash flow closely in upcoming quarters, particularly how share repurchases and debt management impact liquidity. While the strong revenue and net income growth are positive, understanding the sustainability of these trends against cash utilization is key before increasing exposure.

Financial Highlights

revenue

$85.755M

total Assets

$259.177M

total Debt

$0

net Income

$8.209M

gross Margin

71.7%

cash Position

$65.965M

revenue Growth

+17.3%

Revenue Breakdown

Key Numbers

• $85.755M — Total Revenue (Q3 2025) (Increased 17.3% from $73.093M in Q3 2024)
• $8.209M — Net Income (Q3 2025) (Increased 59.2% from $5.155M in Q3 2024)
• $225.928M — Total Revenue (YTD 2025) (Increased 8.0% from $207.399M in YTD 2024)
• $8.452M — Net Income (YTD 2025) (Increased 16.7% from $7.244M in YTD 2024)
• $65.965M — Cash (Sept 30, 2025) (Decreased from $94.367M at Dec 31, 2024)
• $26.562M — Common Stock Repurchases (YTD 2025) (Significant cash outflow for share buybacks)
• $26.250M — Note Payable Payments (YTD 2025) (Significant cash outflow for debt reduction)
• 22,335,582 — Shares Outstanding (Oct 30, 2025) (Reduced from 23,883,475 at Dec 31, 2024 due to repurchases)

Key Players & Entities

• TACTILE SYSTEMS TECHNOLOGY INC (company) — registrant
• AffloVest (company) — acquired airway clearance business
• SEC (regulator) — Securities and Exchange Commission
• FASB (regulator) — Financial Accounting Standards Board
• Swelling Solutions, Inc. (company) — wholly owned subsidiary
• $85.755 million (dollar_amount) — total revenue for three months ended September 30, 2025
• $8.209 million (dollar_amount) — net income for three months ended September 30, 2025
• $26.562 million (dollar_amount) — payments for repurchases of common stock
• $26.250 million (dollar_amount) — payments on note payable
• $65.965 million (dollar_amount) — cash at end of period September 30, 2025

FAQ

Risk Factors

• Reimbursement Uncertainty [high — regulatory]: The company's ability to obtain reimbursement from third-party payers for its products is a significant risk. Changes in reimbursement policies or payer decisions can materially impact revenue and profitability.
• Economic Conditions and Inflation [medium — market]: Adverse economic conditions, including inflation and rising interest rates, pose a risk. These factors can affect consumer spending, supply chain costs (e.g., price increases for supplies and components, wage inflation), and overall business operations.
• Supply Chain Disruptions [medium — operational]: The company is exposed to risks related to supply chain disruptions and the potential loss of key suppliers. This could lead to increased costs or an inability to meet product demand.
• Competition [medium — market]: The entry of new competitors and/or competitive products presents a risk to market share and pricing power. The company must continually innovate and maintain its competitive edge.
• Compliance and Regulatory Changes [medium — regulatory]: Compliance with federal, state, and local government laws and regulations is critical. Changes in these regulations could increase compliance costs or impact business operations.
• Product Obsolescence and Quality [low — operational]: Technological obsolescence or quality issues with the company's products represent an operational risk. Maintaining product quality and relevance is essential for sustained success.
• Liquidity for Business Objectives [medium — financial]: The adequacy of the company's liquidity to pursue its business objectives is a key consideration. While cash decreased, the company must ensure sufficient funds for operations, R&D, and strategic initiatives.

Industry Context

Tactile Systems Technology operates in the medical device industry, specifically focusing on neurostimulation devices for conditions like lymphedema and chronic pain. The industry is characterized by significant R&D investment, stringent regulatory oversight (FDA), and reliance on reimbursement from third-party payers. Key trends include technological advancements, increasing adoption of home-based therapies, and a growing aging population driving demand for chronic condition management solutions.

Regulatory Implications

The company's reliance on third-party payer reimbursement makes it susceptible to changes in healthcare policy and coverage decisions. Compliance with FDA regulations for medical devices is paramount, requiring ongoing investment in quality systems and post-market surveillance. Any shifts in regulatory requirements or reimbursement landscapes could materially impact TCMD's financial performance.

What Investors Should Do

1. Monitor reimbursement trends and payer policies.
2. Analyze operating expense growth relative to revenue.
3. Evaluate the impact of share repurchases and debt payments on cash flow.
4. Assess competitive positioning and innovation pipeline.

Key Dates

• 2025-09-30: End of Q3 2025 — Reported strong revenue and net income growth for the quarter and year-to-date, but a decrease in cash position due to debt payments and stock repurchases.
• 2024-12-31: End of Fiscal Year 2024 — Reported higher cash balance of $94.367 million and a larger number of outstanding shares (23,883,475) compared to Q3 2025.

Glossary

Sales revenue

Revenue generated from the sale of the company's products. (The primary revenue stream for TCMD, showing significant growth in Q3 2025.)

Rental revenue

Revenue generated from renting out the company's products. (A secondary revenue stream that declined in Q3 2025.)

Cost of revenue

Direct costs associated with producing goods or services sold or rented. (Understanding cost of revenue is crucial for analyzing gross profit margins.)

Gross profit

Revenue minus the cost of revenue. (Indicates the profitability of the company's core operations before considering other expenses.)

Note payable

A written promise to pay a specific amount of money on demand or at a specified future date. (The company made significant payments towards its notes payable, impacting cash reserves.)

Common stock repurchases

The company buying back its own shares from the open market. (A significant use of cash in YTD 2025, reducing shares outstanding and potentially increasing EPS.)

Goodwill

An intangible asset that arises when one company acquires another for a price greater than the fair market value of its identifiable net assets. (Represents a significant portion of non-current assets, indicating past acquisitions.)

Retained earnings

The cumulative amount of net income that a company has retained over time, rather than distributing to shareholders as dividends. (Shows the company's historical profitability and its ability to reinvest earnings.)

Year-Over-Year Comparison

Compared to the prior year's comparable periods, Tactile Systems Technology Inc. (TCMD) has demonstrated strong top-line growth, with Q3 2025 total revenue up 17.3% and year-to-date revenue up 8.0%. Net income has also seen substantial improvement, increasing by 59.2% for the quarter and 16.7% year-to-date. However, the company's cash position has decreased significantly from $94.367 million at the end of 2024 to $65.965 million as of September 30, 2025, primarily due to substantial payments on notes payable and common stock repurchases. Operating expenses, particularly sales and marketing and G&A, have also risen, indicating increased investment in growth and operations.

Key Financial Figures

• $0.001 — ch registered Common Stock, Par Value $0.001 Per Share TCMD The Nasdaq Stock Mar

Filing Documents

• tcmd-20250930x10q.htm (10-Q) — 2216KB
• tcmd-20250930xex31d1.htm (EX-31.1) — 20KB
• tcmd-20250930xex31d2.htm (EX-31.2) — 20KB
• tcmd-20250930xex32d1.htm (EX-32.1) — 9KB
• tcmd-20250930xex32d2.htm (EX-32.2) — 9KB
• 0001104659-25-105543.txt ( ) — 8770KB
• tcmd-20250930.xsd (EX-101.SCH) — 44KB
• tcmd-20250930_cal.xml (EX-101.CAL) — 63KB
• tcmd-20250930_def.xml (EX-101.DEF) — 205KB
• tcmd-20250930_lab.xml (EX-101.LAB) — 402KB
• tcmd-20250930_pre.xml (EX-101.PRE) — 326KB
• tcmd-20250930x10q_htm.xml (XML) — 1742KB

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 4 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 33 Item 4.

Controls and Procedures

Controls and Procedures 33

—OTHER INFORMATION

PART II—OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 34 Item 1A.

Risk Factors

Risk Factors 34 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 34 Item 3. Defaults Upon Senior Securities 34 Item 4. Mine Safety Disclosures 34 Item 5. Other Information 34 Item 6. Exhibits 34 2 Table of Contents Forward-Looking Information All statements, other than statements of historical facts, contained in this Quarterly Report on Form 10-Q, including statements regarding our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our business, operations and financial performance and condition, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "ongoing," "plan," "potential," "predict," "project," "should," "target," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this Quarterly Report on Form 10-Q. These risks, uncertainties and other factors include, but are not limited to: our ability to obtain reimbursement from third-party payers for our products; adverse economic conditions, including inflation, rising interest rates or recession; the adequacy of our liquidity to pursue our business objectives; price increases for supplies and components; wage and component price inflation; loss of a key supplier or other supply chain disruptions; entry of new competitors and/or competitive products; compliance with and changes in federal, state and local government laws and regulations; technological obsolescence of, or q

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Tactile Systems Technology, Inc. Condensed Consolidated Balance Sheets (Unaudited) September 30, December 31, (In thousands, except share and per share data) 2025 2024 Assets Current assets Cash $ 65,965 $ 94,367 Accounts receivable, net 37,257 44,937 Net investment in leases 14,843 14,540 Inventories 16,084 18,666 Prepaid expenses and other current assets 7,250 5,053 Total current assets 141,399 177,563 Non-current assets Property and equipment, net 5,460 5,603 Right of use operating lease assets 14,751 16,633 Intangible assets, net 40,023 42,789 Goodwill 31,063 31,063 Deferred income taxes 16,745 18,311 Other non-current assets 9,736 5,962 Total non-current assets 117,778 120,361 Total assets $ 259,177 $ 297,924 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 7,989 $ 5,648 Note payable — 2,956 Accrued payroll and related taxes 14,727 17,923 Accrued expenses 7,862 7,780 Income taxes payable 1,200 270 Operating lease liabilities 3,144 2,980 Other current liabilities 4,264 3,147 Total current liabilities 39,186 40,704 Non-current liabilities Note payable, non-current — 23,220 Accrued warranty reserve, non-current 1,121 1,209 Income taxes payable, non-current 334 239 Operating lease liabilities, non-current 13,587 15,955 Total non-current liabilities 15,042 40,623 Total liabilities 54,228 81,327 Stockholders' equity: Preferred stock, $ 0.001 par value, 50,000,000 shares authorized; none issued and outstanding as of September 30, 2025 and December 31, 2024 — — Common stock, $ 0.001 par value, 300,000,000 shares authorized; 22,335,582 shares issued and outstanding as of September 30, 2025; 23,883,475 shares issued and outstanding as of December 31, 2024 22 24 Additional paid-in capital 160,62

View Full Filing

View this 10-Q filing on SEC EDGAR